Premium
NYSE-listed Par Pharmaceutical, Inc has acquired Ethics Bio Lab Pvt Ltd, a Chennai-based contract research organisation (CRO) in an all cash transaction for around $20 million (Rs 125 crore), VCCircle learns.This marks the third such in-bound acquisition by Par Pharma in a group firm of same set of entrepreneurs. It ......
This is a Premium article. Please subscribe or log in to read the full story!
Here's a selection of our recent premium content.
Already a member? Click here to log in.
